Clinical Trial Update: Preoperative Therapy of Super-selective Tumor Artery Embolization Combined With Toripalimab and Axitinib in Advanced RCC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating preoperative therapy with super-selective tumor artery embolization combined with toripalimab and axitinib in advanced re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Axitinib (Axitinib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Tianjin Medical University Second Hospital | Conditions: Renal Cell Carcinoma (RCC) | Phase 2 | Status: RECRUITING